Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions show moderate agreement and interest, with responses emphasizing survival benefits linked to MHT and referencing specifics such as higher survival rates for women with HGSC. Phrases like 'may improve survival' and mentions of age groups reflect a focus on clinical implications, demonstrating engaged and somewhat impactful responses.
Most discussions acknowledge the potential positive effects of MHT on survival, especially for HGSC, indicating a general agreement with the publication's findings.
Posts demonstrate moderate curiosity, focusing on the survival benefits and clinical implications, though not extensively exploring broader issues.
Several discussions actively interpret key points like the specific impacts on subgroups and potential treatment considerations, showing deep engagement.
The discussions highlight the importance of these findings for clinical decision-making and future research, but the overall influence on practice appears moderate.
NOW ONLINE Authors from @QIMRB_Institute suggest menopausal hormone therapy may improve survival for #OvarianCancer patients and help manage symptoms in younger women
Pre-#diagnosis #MHT use was associated with improved #survival, particularly in #HGSC. Among women ≤55 years, use of MHT following #treatment was not associated with #poorersurvival for HGSC. #highgrade #serouscarcinoma https://t.co/DAAlUIqDf3 https://t.co/QVIztUdaxC
Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival. Women who used MHT before diagnosis showed better survival rates, especially for high-grade serous carcinoma. Posttreatment MHT…
NOW ONLINE Authors from @QIMRB_Institute suggest menopausal hormone therapy may improve survival for #OvarianCancer patients and help manage symptoms in younger women
Pre-#diagnosis #MHT use was associated with improved #survival, particularly in #HGSC. Among women ≤55 years, use of MHT following #treatment was not associated with #poorersurvival for HGSC. #highgrade #serouscarcinoma https://t.co/DAAlUIqDf3 https://t.co/QVIztUdaxC